Search clinical trials for: CT-322

Total 4403 results

Bristol-Myers Squibb

Withdrawn

Japanese Phase 1 Study of BMS-844203 (CT322)

Neoplasms

Japan
Adnexus, A Bristol-Myers Squibb R&D Company

Completed

CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma

Cancer

United States
Creabilis SA

Terminated

CT 327 in the Treatment of Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Switzerland
Creabilis SA

Completed

CT 327 in the Treatment of Psoriasis Vulgaris

Psoriasis

Switzerland, United States, United Kingdom
Xuzhou Central Hospital

Unknown

The Comparative Study of OCT，Gemstone CT and 320-detector Row Spiral CT for Evaluating Restenosis of Coronary Artery Stent

Coronary Heart Disease

China
Frequency Therapeutics

Completed

FX-322 in Adults With Stable Sensorineural Hearing Loss

Sensorineural Hearing Loss | Noise Induced Hearing Loss | Sudden Sensorineural Hearing Loss

United States
Enanta Pharmaceuticals, Inc

Completed

Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers

MRSA, SSTI

United States
Johns Hopkins University
Toshiba America Medical Systems, Inc.

Completed

Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography (Core320)

Ischemia | Myocardial Ischemia | Heart Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases

United States, Canada, Singapore, Netherlands, Brazil, Denmark, Germany, Japan
Frequency Therapeutics

Completed

FX-322 in Adults With Acquired Sensorineural Hearing Loss

Hearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing Loss

United States
Frequency Therapeutics

Completed

FX-322 in Adults With Age-Related Sensorineural Hearing Loss

Hearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing Loss

United States
Frequency Therapeutics

Completed

FX-322 in Adults With Severe Sensorineural Hearing Loss

Hearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing Loss

United States
Frequency Therapeutics

Completed

First in Human Safety Study of FX-322 in Adults Undergoing Cochlear Implantation

Hearing Loss

Australia
Adnexus, A Bristol-Myers Squibb R&D Company

Unknown

CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme

Glioblastoma Multiforme

United States
Adnexus, A Bristol-Myers Squibb R&D Company

Unknown

CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan

Brain and Central Nervous System Tumors | Recurrent Glioblastoma Multiforme

United States
Yonsei University

Completed

Comparison of Image Quality of Coronary Computed Tomography Angiography bEtweeN High concenTRATion and Low concEntration Contrast Agents(CONCENTRATE Trial)

Coronary Artery Disease

Korea, Republic of
Fudan University

Active, not recruiting

Acute Health Effects of High Temperature Exposure

Cognitive Function | Cardiovascular System | Respiratory System

China
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Fetal Neurobehavioral Development in Methadone Maintained Pregnancies

Opioid-Related Disorders

United States
Enanta Pharmaceuticals, Inc

Completed

Safety and Pharmacokinetics of Ascending Single Oral Doses of EDP-322 in Nonfasting and Fasting Healthy Volunteers

Methicillin-resistant Staphylococcus Aureus | Skin and Soft Tissue Infections

United States
He Eye Hospital

Not yet recruiting

Point of Care Test of LTA Level in Tear Fluid, Measured With a POCT Test, in DE Patients Following IPL Treatment

Dry Eye
Shenzhen Xbiome Biotech Co., Ltd.
Beijing Improve-Quality Tech.Co., Ltd.

Recruiting

Safety and Tolerability of FMT Capsules in Healthy Volunteers

Acute-graft-versus-host Disease

China
Thallion Pharmaceuticals

Terminated

Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma

Melanoma

United States, Canada
Ichnos Sciences SA
Glenmark Pharmaceuticals S.A.

Terminated

Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer

Breast Cancer

United States
AbbVie

Completed

Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body of Adult Participants With Human Immuno-Deficiency Virus (HIV-1)

Human Immunodeficiency Virus (HIV)

United States, Puerto Rico
Thallion Pharmaceuticals

Completed

Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma

Carcinoma, Renal Cell

France
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis

Moderate to Severe Atopic Dermatitis

China
PreCision Dermatology, Inc.

Unknown

An Evaluation of PDI-320 in Comparison to Its Monads in Adults With Rosacea

Rosacea

United States
Shenzhen TargetRx, Inc.
The First Affiliated Hospital of Soochow University

Not yet recruiting

TGRX-326 Pharmacokinetic Mass Balance

Non Small Cell Lung Cancer
Stragen France

Completed

First-In-Human PainCart Study for STR-324

Pain

Netherlands
TaiwanJ Pharmaceuticals Co., Ltd

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of JKB-122 in Patients With NASH and Fibrosis

Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Frequency Therapeutics

Completed

FX-322 in Sensorineural Hearing Loss

Sensorineural Hearing Loss

United States
Castle Creek Pharmaceuticals, LLC

Completed

A Study of Sensitizing Potential of Diacerein 1% Ointment in Healthy Subjects

Healthy

United States
Chong Kun Dang Pharmaceutical

Unknown

A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects

GERD

Korea, Republic of
Kowa Research Institute, Inc.

Completed

Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects

Hyperlipidemia

United States
Medicines Development for Global Health

Completed

A Pharmacokinetic and Safety Study of Moxidectin to Identify an Optimal Dose for Treatment of Children 4 to 11 Years

Onchocerciasis

Ghana
Lumenis Be Ltd.

Completed

Impact of Synergistic Sequential Treatment (SST)

Improvement of Wrinkles/Elastosis as Well as General Skin Tone

United States
Castle Creek Pharmaceuticals, LLC

Terminated

Safety and Efficacy of Diacerein 1% Ointment for Subjects With Epidermolysis Bullosa Simplex (EBS)

Epidermolysis Bullosa Simplex

United States, Israel, Australia, Austria, France, Germany, Netherlands, United Kingdom
Bracco Diagnostics, Inc

Completed

Kidney Damage in Patients With Moderate Fall in eGFR

Coronary Artery Stenosis

Canada, United States
Second Affiliated Hospital, School of Medicine,...

Recruiting

Pulsed Dye Laser and Intense Pulsed Light Configured With Different Wavelength Bands in Improving Erythematotelangiectatic Rosacea

Erythematotelangiectatic Rosacea

China
Valneva Austria GmbH

Completed

Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study

Japanese Encephalitis

Australia, United States, Germany
Remix Therapeutics

Recruiting

Study of REM-422 in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Adenoid Cystic Carcinoma | Metastatic Adenoid Cystic Carcinoma | Recurrent Adenoid Cystic Carcinoma

United States
Celgene

Completed

A Study of CC-122 to Assess the Safety and Tolerability in Japanese Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma (NHL)

Lymphoma, Non-Hodgkin

Japan
Nuvation Bio Inc.

Terminated

Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors

Glioma | Breast Cancer | Glioblastoma | Advanced Breast Cancer | Prostate Cancer | Metastatic Breast Cancer | Recurrent Glioblastoma | Breast Carcinoma | Castration-resistant Prostate Cancer | Prostate Neoplasm | Cancer of the Prostate | Prostatic Cancer | Glioma, Malignant | Cancer of Breast | Malignant Tumor of Breast and other conditions

United States
Beijing InnoCare Pharma Tech Co., Ltd.

Active, not recruiting

A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSL

PCNSL | Secondary Central Nervous System Lymphoma

China
Beijing InnoCare Pharma Tech Co., Ltd.

Active, not recruiting

A Study to Evaluate ICP-022 in Patients With CLL/ SLL

CLL/SLL

China
Kartos Therapeutics, Inc.

Completed

A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma

Cancer | Glioblastoma | Multiple Myeloma | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology Patients

United States, France, Netherlands
Threshold Pharmaceuticals

Terminated

A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma

Metastatic Melanoma

United States, Canada
Celgene

Completed

Radiolabeled Study of CC-122 in Healthy Subjects

Healthy Volunteers

United States
Celgene

Completed

A Study to Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment

Renal Insufficiency

United States
Sarcoma Alliance for Research through Collaboration
Threshold Pharmaceuticals

No longer available

SARC021C: A Continuation Study of TH-CR-406/SARC021

Soft Tissue Sarcoma
Threshold Pharmaceuticals

Unknown

A Cardiac Safety Study of TH-302 in Patients With Advanced Solid Tumors

Solid Tumors

United States

Search clinical trials for: CT-322

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations